This has been seen in tuberous sclerosis, where the tuberin/hamartin complex loses its inhibitory impact on Rheb signaling while losing its stimulatory impact on the guanosine triphosphatase (GTPase)-activating protein for Krev-1=rap1a. This evidence concerns the gene RAP1A and tuberous sclerosis.